According to Lejawa et al., MUO subjects had higher levels of visfatin than did people with MHO and MHNW, implying that this adipokine may have an effect on the development of obesity-related metabolic disorders (Table 2) [79]. Here, NAMPT is linked to obesity due to melanocortin 4 receptor deficiency.